Compounders Research Compare

PolyPid Ltd.(PYPD)

Biotechnology · Petah Tikva, HM

$5.17-0.03 (-0.58%)

Delayed quote: Oct 6, 2026, 1:54 PM EDT

About PolyPid Ltd.

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.

Petah Tikva, HM

72 employees

www.polypid.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Dikla Czaczkes Akselbrad

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T17:57:55.768Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:57:55.768Z.

Quote observation: 2026-10-06T17:54:29.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 98,662,052
TTM free cash flow · period ending 2020-06-30: N/A

FMP input reference: d00a9c235f8f3f2200d332a4911885706ef223ec632fccfa45bb3326c1a5dd06

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PYPD Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PYPD Competitors' Price/FCF Ratio

PolyPid Ltd.

Current

Market Cap

$98.66M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Conexeu Sciences Inc.

Market Cap

$98.07M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Milestone Pharmaceuticals Inc.

Market Cap

$97.30M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Korro Bio, Inc.

Market Cap

$97.24M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

The Joint Corp.

Market Cap

$102.35M

Price/FCF Ratio

24.21

TTM Avg

107.29

3Y Avg

57.88

5Y Avg

61.33

OnKure Therapeutics, Inc.

Market Cap

$103.06M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Polaryx Therapeutics, Inc. Common Stock

Market Cap

$103.68M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Anixa Biosciences, Inc.

Market Cap

$104.96M

Price/FCF Ratio

N/A

TTM Avg

17.97

3Y Avg

17.97

5Y Avg

17.97

Park Dental Partners, Inc. Common Stock

Market Cap

$92.33M

Price/FCF Ratio

0.02

TTM Avg

3.14

3Y Avg

3.14

5Y Avg

3.14

Definitive Healthcare Corp.

Market Cap

$105.20M

Price/FCF Ratio

3.68

TTM Avg

4.64

3Y Avg

13.17

5Y Avg

35.61

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
PolyPid Ltd. (PYPD)	$98.66M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$98.07M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.30M	N/A	N/A	N/A	N/A
Korro Bio, Inc. (KRRO)vs ›	$97.24M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.35M	24.21	107.29	57.88	61.33
OnKure Therapeutics, Inc. (OKUR)vs ›	$103.06M	N/A	N/A	N/A	N/A
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$103.68M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$104.96M	N/A	17.97	17.97	17.97
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.33M	0.02	3.14	3.14	3.14
Definitive Healthcare Corp. (DH)vs ›	$105.20M	3.68	4.64	13.17	35.61

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics